Industry Symposium

To B-cell maturation antigen (BCMA) or not to BCMA? Addressing unanswered questions in relapsed refractory multiple myeloma (RRMM)

Thursday 23rd May 2024, 12:30–14:00 CEST
Paris, France

FACULTY

Professor Paula Rodríguez-Otero

Bio

Dr Roberto Mina

Bio

Professor Philippe Moreau

Bio

Professor Jesus San Miguel

Bio

AGENDA
12:30 – 12:35 Welcome and introduction
Prof. Jesús San Miguel (Chair)
University of Navarra, Spain
12:35 – 12:50 An expanding landscape: Reviewing the available treatment options in TCE RRMM
Prof. Philippe Moreau
University Hospital of Nantes, France
12:50 – 13:10 Who, what and how? Tailoring treatment selection in challenging populations
Prof. Paula Rodríguez-Otero
University of Navarra, Spain
13:10 – 13:25 Panel discussion 1: Treatment selection
All faculty, moderated by Prof. Jesús San Miguel
13:25 – 13:45 Time to step up? Optimising T-cell redirecting regimens
Dr Roberto Mina
University of Torino, Italy
13:45 – 14:00 Panel discussion 2: Treatment optimisation
All faculty, moderated by Prof. Jesús San Miguel